Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis

Infection and Immunity

Volumn 70, Issue 12, 2002, Pages 6589-6591

  Kocyigit, Abdurrahim ^a,c   Gur, Selahaddin ^a   Gurel, Mehmet S ^a   Bulut, Vedat ^b   Ulukanligil, Mustafa ^a  

^a HARRAN UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MEGLUMINE ANTIMONATE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ERADICATION THERAPY; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHOOL CHILD; SKIN LEISHMANIASIS;

ADOLESCENT; ADULT; ANTIMONY; ANTIPROTOZOAL AGENTS; CHILD; CYTOKINES; HUMANS; INFLAMMATION; LEISHMANIASIS, CUTANEOUS; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; TREATMENT OUTCOME;

EID: 0036892199     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.12.6589-6591.2002     Document Type: Article

References (26)

1. Adhuna, A., P. Saltora, and R. Bhatnagar. 2000. Nitric oxide induced expression of stress proteins in virulent and avirulent promastigotes of Leishmania donovani. Immunol. Lett. 71:171-176.
2. Akman, L., H. S. Aksu, R. Q. Wang, S. Ozensoy, Y. Ozbel, Z. Alkan, M. A. Ozcel, G. Culha, K. Ozcan, S. Uzun, H. R. Memisoglu, and K. P. Chang. 2000. Multi-site DNA polymorphism analyses of Leishmania isolates define their genotypes predicting clinical epidemiology of leishmaniasis in a specific region. J. Eukaryot. Microbiol. 47:545-554.
3. Assreuy, J., F. Q. Cunha, M. Epperlein, A. Noronha-Dutra, C. A. O'Donnell, F. Y. Liew, and S. Moncada. 1994. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur. J. Immunol. 24:672-676.
4. Belosevic, M., C. E. Davis, M. S. Meltzer, and C. A. Nacy. 1988. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J. Immunol. 141:890-896.
5. Berger, B. J., and A. H. Fairlamb. 1992. Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases. Parasitology 105:71-78.
6. Brunet, L. R. 2001. Nitric oxide in parasitic infections. Int. Immunopharmacol. 1:1457-1467.
7. Coutinho, S. G., A. M. Da-Cruzi, A. L. Bertho, M. A. Santiago, and P. De-Luca. 1998. Immunologic patterns associated with cure in human American cutaneous leishmaniasis. Braz. J. Med. Biol. Res. 3:139-142.
8. Erel, O., A. Kocyigit, V. Bulut, and M. S. Gurel. 1999. Reactive nitrogen and oxygen intermediates in patients with cutaneous leishmaniasis. Mem. Inst. Oswaldo Cruz 94:179-183.
9. Gramiccia, M., S. Bettini, and S. Yasarol. 1984. Isoenzyme characterization of Leishmania isolates from human cases of cutaneous leishmaniasis in Urfa, south-east Turkey. Trans. R. Soc. Trop. Med. Hyg. 78:568.
10. Green, S. J., R. M. Crawford, J. T. Hockmeyer, M. S. Meltzer, and C. A. Nacy. 1990. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J. Immunol. 145:4290-4297.
11. Hammouda, N. A., E. A. Rashwan, E. D. Hussien, I. Abo el-Naga, and F. M. Fathy. 1995. Measurement of respiratory burst of TNF and IL-1 cytokine activated murine peritoneal macrophages challenged with Toxoplasma gondii. J. Egypt. Soc. Parasitol. 25:683-691.
12. Hirota, K., T. Akahoshi, H. Endo, H. Kondo, and S. Kashiwazaki. 1992. Production of interleukin 8 by cultured synovial cells in response to interleukin 1 and tumor necrosis factor. Rheumatol. Int. 12:13-16.
13. Holaday, B. J., M. M. Pompeu, T. Evans, D. N. Braga, M. J. Texeira, Q. Sousa, M. D. Sadick, A. W. Vasconcelos, J. S. Abrams, and R. D. Pearson. 1993. Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. J. Infect. Dis. 167:411-417.
14. Ibrahim, M. E., M. Hag-Ali, A. M. el-Hassan, T. G. Theander, and A. Kharazmi. 1994. Leishmania resistant to sodium stibogluconate: Drug-associated macrophage-dependent killing. Parasitol. Res. 80:569-574.
15. Koch, A. E., S. L. Kunkel, J. C. Burrows, H. L. Evanoff, G. K. Haines, R. M. Pope, and R. M. Strieter. 1991. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J. Immunol. 147:2187-2195.
16. Liew, F. Y., and C. A. O'Donnell. 1993. Immunology of leishmaniasis. Adv. Parasitol. 2:161-259.
17. Luettig, B., C. Steinmuller, G. E. Gifford, H. Wagner, and M. L. Lohmann-Matthes. 1989. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J. Natl. Cancer Inst. 1:669-675.
18. Murray, H. W., M. J. Oca, A. M. Granger, and R. D. Schreiber. 1989. Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. J. Clin. Investig. 83:1253-1257.
19. Rais, S., A. Perianin, M. Lenoir, A. Sadak, D. Rivollet, M. Paul, and M. Deniau. 2000. Sodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human blood. Antimicrob. Agents Chemother. 44:2406-2410.
20. Roberts, W. L., and P. M. Rainey. 1993. Antileishmanial activity of sodium stibogluconate fractions. Antimicrob. Agents Chemother. 37:1842-1846.
21. Sodhi, S., N. K. Ganguly, N. Malla, and R. C. Mahajan. 1990. Effect of sodium stibogluconate on the status of interleukin-1 production in normal and Leishmania donovani infected BALB/c mice. Indian J. Med. Res. 91:344-348.
22. Stimpel, M., A. Proksch, H. Wagner, and M. L. Lohmann-Matthes. 1984. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea. Infect. Immun. 46:845-849.
23. Titus, R. G., B. Sherry, and A. Cerami. 1989. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 170:2097-2104.
24. Toledo, V. P., W. Mayrink, K. J. Gollob, M. A. Oliveira., C. A. Costa, O. Genaro, J. A. Pinto, and L. C. Afonso. 2001. Immunochemotherapy in American cutaneous leishmaniasis: Immunological aspects before and after treatment. Mem. Inst. Oswaldo Cruz 96:89-98.
25. Van Damme, J., R. A. Bunning, R. Conings, R. Graham, G. Russell, and G. Opdenakker. 1990. Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin 8. Cytokine 2:106-111.
26. Yu, C. L., K. H. Sun, S. C. Shei, C. Y. Tsai, S. T. Tsai, J. C. Wang, T. S. Liao, W. M. Lin, H. L. Chen, and H. S. Yu. 1994. Interleukin 8 modulates interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha release from normal human mononuclear cells. Immunopharmacology 27:207-214.